Editorial to the Feature article “Artemisinin anti-malarial drugs in China" | |
Zhang Ao | |
刊名 | Acta Pharmaceutica Sinica B
![]() |
2016 | |
卷号 | 6期号:2页码:114 |
关键词 | Therapeutics. Pharmacology RM1-950 |
ISSN号 | 2211-3835 |
DOI | 10.1016/j.apsb.2016.03.001 |
英文摘要 | The winning of the 2015 Nobel Prize in Physiology or Medicine by William C. Champbell, Satoshi Omura, and the Chinese scientist Youyou Tu marks their pioneering discoveries of novel therapeutic drugs to treat highly devastating parasitic diseases that mostly affect the world's poorest populations, such as river blindness, lymphatic filariasis, and malaria. More appreciably, this is also the first time that a Chinese scientist was awarded this Noble Prize. Professor Youyou Tu is a natural product medicinal chemist at the China Academy of Chinese Medical Sciences who made significant contribution to the discovery of artemisinin as an antimalarial drug. Back in the 1960s, malaria was the most common and widespread parasitic disease in tropical and subtropical regions, which killed millions of lives annually. Fortunately, China, under the “whole nation" system, launched a multidisciplinary drug discovery team that involved hundreds of scientists nationwide, including Youyou Tu. Their efforts led to the discovery of many antimalarial drugs or drug candidates, including artemisinin, dihydroartemisinin, artemether, and artesunate. Several of these drugs have been used since then as the standard treatment for P. falciparum and saved millions of malarial patients worldwide. |
语种 | 英语 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/283840] ![]() |
专题 | 中国科学院上海药物研究所 |
作者单位 | 中国科学院上海药物研究所 |
推荐引用方式 GB/T 7714 | Zhang Ao. Editorial to the Feature article “Artemisinin anti-malarial drugs in China"[J]. Acta Pharmaceutica Sinica B,2016,6(2):114. |
APA | Zhang Ao.(2016).Editorial to the Feature article “Artemisinin anti-malarial drugs in China".Acta Pharmaceutica Sinica B,6(2),114. |
MLA | Zhang Ao."Editorial to the Feature article “Artemisinin anti-malarial drugs in China"".Acta Pharmaceutica Sinica B 6.2(2016):114. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论